FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Thermo Fisher Scientific Inc. Stock AnalysisComprehensive stock analysis for Thermo Fisher Scientific Inc. (TMO) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisTMO
TMO
Thermo Fisher Scientific Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TMO
Home🔹Stocks🔹Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

🇺🇸TMO•NYSE

Thermo Fisher Scientific Inc.

🇺🇸TMO•NYSE
Market cap
$226.62B
Sentiment

Your view on TMO

Mkt Cap
$226.62B
Sentiment
Your view
TMO
Thermo Fisher Scientific Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TMO
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Thermo Fisher Scientific Inc.

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Marc N. Casper
Headquarters
168 Third Avenue, Waltham, MA, US
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Marc N. Casper
Headquarters
168 Third Avenue, Waltham, MA, US
Description

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.

The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products.

Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research.

It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD.

Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Thermo Fisher Scientific Inc., and the rating behind it. TMO last traded at $609.82, 32.9× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Thermo Fisher Scientific Inc.. Starting points for Thermo Fisher Scientific Inc.: P/E 32.9, EPS $18.81, beta 0.85 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Thermo Fisher Scientific Inc.. Thermo Fisher Scientific Inc. paid $1.80 per share over the last year — a 0.3% yield at the current $609.82 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Thermo Fisher Scientific Inc.. Trailing twelve-month EPS for Thermo Fisher Scientific Inc. stands at $18.81. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Thermo Fisher Scientific Inc.. Thermo Fisher Scientific Inc. has reported as a listed company since 1980. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Thermo Fisher Scientific Inc. valued side by side against its closest peers. Thermo Fisher Scientific Inc. is measured against Medical - Diagnostics & Research peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Thermo Fisher Scientific Inc., and how their positions are changing. At a $226.62B market value, institutional positions materially move Thermo Fisher Scientific Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Thermo Fisher Scientific Inc. executives and directors. Shares of Thermo Fisher Scientific Inc. have traded between $385.46 and $610.97 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Thermo Fisher Scientific Inc.. Thermo Fisher Scientific Inc. is a $226.62B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Thermo Fisher Scientific Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Thermo Fisher Scientific Inc.. Coverage tracks Thermo Fisher Scientific Inc. within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • A — Agilent Technologies, Inc.
  • ABT — Abbott Laboratories
  • AMGN — Amgen Inc.
  • AZN — AstraZeneca PLC
  • DHR — Danaher Corporation
  • IQV — IQVIA Holdings Inc.
  • ISRG — Intuitive Surgical, Inc.
  • MRK — Merck & Co., Inc.

More Medical - Diagnostics & Research companies

  • SKHHY — Sonic Healthcare Limited
  • SLDX — Stella Diagnostics Inc.
  • SPDE — Speedus Corp.
  • SZLSF — StageZero Life Sciences Ltd.
  • TDSGF — Telo Genomics Corp.
  • TELO.V — Telo Genomics Corp.
  • THOXF — BioPorto A/S
  • TMO.NE — Thermo Fisher Scientific Inc.
  • TOMDF — Todos Medical Ltd.
  • TTOO — T2 Biosystems, Inc.
  • TWST — Twist Bioscience Corporation
  • VCYT — Veracyte, Inc.

ETFs holding Thermo Fisher Scientific Inc.

  • AGIQ — SoFi Agentic AI ETF (6.02%)
  • DHLX — Diamond Hill Funds (5.22%)
  • HHL.TO — Harvest Healthcare Leaders Income ETF (5.20%)
  • HRTS — Tema Cardiovascular and Metabolic ETF (5.16%)
  • PINK — Simplify Health Care ETF (5.13%)
  • RSMV — Relative Strength Managed Volatility Strategy ETF (4.84%)

News

Latest Market News